1-4 of 4
Russell J. Schilder
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract C095: Antitumor activity of STRO-002, a novel anti-folate receptor-α (FRα) antibody drug conjugate (ADC), in patient-derived xenograft (PDX) models and preliminary phase I dose escalation safety outcomes in patients with ovarian carcinoma (OC)

Free
Denise Uyar, Russell J Schilder, R Wendel Naumann, Fadi S Braiteh, Erika Hamilton, Sami Diab, John Moroney, Richard T Penson, Jennifer Smith, Cristina Abrahams, Michael Palumbo, Venita DeAlmeida, Shannon Matheny, Arturo Molina
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (12_Supplement): C095.
https://doi.org/10.1158/1535-7163.TARG-19-C095
Published: 01 December 2019
View article titled, Abstract C095: Antitumor activity of STRO-002, a novel anti-folate receptor-α (FRα) antibody drug conjugate (ADC), in patient-derived xenograft (PDX) models and preliminary phase I dose escalation safety outcomes in patients with ovarian carcinoma (OC)
Journal Articles

A Phase I Study of the SMAC-Mimetic Birinapant in Adults with Refractory Solid Tumors or Lymphoma

Free
Ravi K. Amaravadi, Russell J. Schilder, Lainie P. Martin, Myron Levin, Martin A. Graham, David E. Weng, Alex A. Adjei
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (11): 2569–2575.
https://doi.org/10.1158/1535-7163.MCT-15-0475
Published: 03 November 2015
View article titled, A Phase I Study of the SMAC-Mimetic Birinapant in Adults with Refractory Solid Tumors or Lymphoma
Open the PDF for A Phase I Study of the SMAC-Mimetic Birinapant in Adults with Refractory Solid Tumors or Lymphoma in another window
Includes: Supplementary data
Journal Articles

Potential Role of mTORC2 as a Therapeutic Target in Clear Cell Carcinoma of the Ovary

Free
Takeshi Hisamatsu, Seiji Mabuchi, Yuri Matsumoto, Mahiru Kawano, Tomoyuki Sasano, Ryoko Takahashi, Kenjiro Sawada, Kimihiko Ito, Hirohisa Kurachi, Russell J. Schilder, Joseph R. Testa, Tadashi Kimura
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (7): 1367–1377.
https://doi.org/10.1158/1535-7163.MCT-12-1185
Published: 07 July 2013
View article titled, Potential Role of mTORC2 as a Therapeutic Target in Clear Cell Carcinoma of the Ovary
Open the PDF for Potential Role of mTORC2 as a Therapeutic Target in Clear Cell Carcinoma of the Ovary in another window
Includes: Supplementary data
Journal Articles

Abstract A25: Phase 1 PK/PD analysis of the Smac-mimetic TL32711 demonstrates potent and sustained cIAP1 suppression in patient PBMCs and tumor biopsies.

Free
Martin A. Graham, Yasu Mitsuuchi, Jennifer Burns, Srinivas Chunduru, Christopher Benetatos, Mark McKinlay, David Weng, Michael J. Wick, Anthony W. Tolcher, Kyriakos Papadopoulos, Ravi Amaravadi, Russell J. Schilder, Alex Adjei, Patricia LoRusso
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): A25.
https://doi.org/10.1158/1535-7163.TARG-11-A25
Published: 12 November 2011
View article titled, Abstract A25: Phase 1 PK/PD analysis of the Smac-mimetic TL32711 demonstrates potent and sustained cIAP1 suppression in patient PBMCs and tumor biopsies.